For more than six decades, Anuh Pharma has manufactured Active Pharmaceutical Ingredients in Maharashtra. Today we operate three GMP sites: two API facilities in MIDC Tarapur, Boisar — Tarapur Unit E-17 & E-18 (Plots E-17/3, 17/4 & E-18) and Tarapur Unit F-10 (Plot F-10/1, inaugurated in October 2026) — and Turbhe Unit D-5, a dedicated corticosteroid facility in Navi Mumbai. All three are backed by our DSIR-recognised R&D centre at Mahape.
Tarapur Unit E-17 & E-18
E-17/3 & 17/4, E-18, MIDC Tarapur, Boisar, Dist. Palghar 401 506, Maharashtra
Our largest multi-purpose plant produces Active Pharmaceutical Ingredients and intermediates at commercial scale — macrolides, anti-TB, anti-malarial and anti-diabetic APIs — approved by the USFDA, EDQM, EU-GMP, WHO and NMPA (China).
Tarapur Unit F-10
Plot F-10/1, MIDC Tarapur, Boisar, Dist. Palghar 401 506, Maharashtra
Inaugurated in October 2026 in the same MIDC Tarapur industrial area as Tarapur Unit E-17 & E-18 — a modern, multi-storey cGMP facility for multi-purpose API manufacturing, adding 575 MTPA of capacity and ~69 KL of reactor volume, with its own production, quality-control and warehousing, now being integrated into Anuh Pharma's quality systems.
Turbhe Unit D-5
D-5/8 & 5/9, T.T.C. Industrial Area, MIDC Turbhe, Navi Mumbai 400 703, Maharashtra
A facility dedicated to corticosteroid Active Pharmaceutical Ingredients, purpose-built for the contained handling these potent molecules demand. It manufactures 16 corticosteroid APIs under GMP and WHO-GMP systems, with Written Confirmation and DMF support.
Our sites run under a rigorous quality management system, with in-house quality control, documented procedures and a strong regulatory filing track record — including a USFDA inspection closed with zero 483 observations and an EDQM Attestation of Inspection.